检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]解放军第251医院心内一科,河北张家口075000
出 处:《临床荟萃》2017年第7期561-564,共4页Clinical Focus
基 金:河北省科技计划项目(16277707D);河北省医学科学研究重点课题计划(20150190)
摘 要:心律失常性心肌病是一种特殊类型的心肌疾病,其发病的机制主要是由于出现快速或缓慢性心律失常导致血流动力学发生改变,首先出现心肌电重构,继而出现心肌机械重构。心律失常性心肌病的表现不一,有的以心房衰竭为主,有的以心室衰竭为主,目前对于心律失常性心肌病的研究逐渐深入,治疗方法逐渐增多,但主要有药物治疗、介入治疗两种方式。本文主要从心房与心室心肌病分子机制方面进行综述,以提高该病的治愈率。Arrhythmogenic cardiomyopathy is a special type of cardiac diseases, its etiopathogenesis is mainly due to the emergence of fast or slow arrhythmiainduced hemodynamic changes, it first appears in electrical remodeling of myocardium followed by myocardial mechanical remodeling. Arrhythmogenic cardiomyopathy performed diversely with mainly manifested as atrial heart failure, and others mainly manifested as ventricular heart failure, at present, the study of arrhythmia cardiomyopathy is gradually deepened, treatment methods increased gradually, but mainly include drug therapy and interventional therapy. In this review, we discussed the molecular mechanisms of atrial and ventricular cardiomyopathy in order to improve the cure rate of this disease.
分 类 号:R541.7[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.44